Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Securing Your Small Business’s Profit

Unfortunately, if you don’t take the right steps, others will be able to directly copy your work and profit from it and there won’t be a whole lot that you can do. . . . → Read More: Securing Your Small Business’s Profit

Biotechs Collaborate on Immunotherapies in $1.2B Deal

Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers. . . . → Read More: Biotechs Collaborate on Immunotherapies in $1.2B Deal

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding

Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s

A biotechnology company specializing in stem cell therapeutics is licensing a process from Texas A&M University to produce exosomes — cellular delivery packages — from adult stem cells as possible therapies for Alzheimer’s disease. . . . → Read More: Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s

Biotech, Pharma Dominate U.S. Academic Patents

In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total. . . . → Read More: Biotech, Pharma Dominate U.S. Academic Patents

Start-Up Licenses Children’s Myopia-Control Contact Lens

A start-up enterprise spun-off from Hong Kong Polytechnic University is licensing the technology for a customized contact lens that controls and prevents further myopia in children. . . . → Read More: Start-Up Licenses Children’s Myopia-Control Contact Lens

Institute, Company Partner on Implanted Neuro Device

A research center in Switzerland and medical engineering company in Germany are developing an implanted device to measure signals and treat disorders affecting the brain. . . . → Read More: Institute, Company Partner on Implanted Neuro Device

Sangamo, Pfizer Partner on ALS Gene Therapy

Drug maker Pfizer Inc. is licensing and collaborating on a gene therapy technology from Sangamo Therapeutics Inc. to treat amyotrophic lateral sclerosis, or ALS, and a related neurodegenerative disease. . . . → Read More: Sangamo, Pfizer Partner on ALS Gene Therapy

Biotechs Partner on HPV Cancer Immunotherapies

Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV. . . . → Read More: Biotechs Partner on HPV Cancer Immunotherapies